Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04585763 · ClinicalTrials.gov registry record · NA
Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System
A NA study, sponsored by Shockwave Medical.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT04585763 is a NA study that has completed, run by Shockwave Medical. The registered enrollment target is 37 participants.
The verdict
NCT04585763, a NA study, has completed, sponsored by Shockwave Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
Prospective, multi-center, single-arm study of the M5+ Peripheral IVL system to treat calcified peripheral arteries.
Interventions
- DEVICE Shockwave Medical M5+ Peripheral Intravascular Lithotripsy (IVL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2021-02-16 |
| Est. Completion | 2022-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04585763
The ClinicalTrials.gov registry entry for NCT04585763 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shockwave Medical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Shockwave Medical M5+ Peripheral Intravascular Lithotripsy (IVL) is the first listed.
NCT04585763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04585763 about?
NCT04585763 is a clinical study titled "Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System". Prospective, multi-center, single-arm study of the M5+ Peripheral IVL system to treat calcified peripheral arteries.
What is the current status of trial NCT04585763?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2021-02-16. Estimated completion is 2022-11-21.
What interventions are being tested in trial NCT04585763?
The interventions under investigation include: Shockwave Medical M5+ Peripheral Intravascular Lithotripsy (IVL) (DEVICE).
Who is sponsoring clinical trial NCT04585763?
This trial is sponsored by Shockwave Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.